capromab-pendetide and Lymphoma--Non-Hodgkin

capromab-pendetide has been researched along with Lymphoma--Non-Hodgkin* in 2 studies

Other Studies

2 other study(ies) available for capromab-pendetide and Lymphoma--Non-Hodgkin

Article	Year
Detection of Recurrent Non-Hodgkin Lymphoma on In-111 Capromab Pendetide Imaging. Clinical nuclear medicine, 2015, Volume: 40, Issue:7 A 73-year-old man presented with a rising prostate-specific antigen (PSA) level 5 years following brachytherapy for prostate cancer. In-111 capromab pendetide (ProstaScint) whole-body planar imaging revealed abnormal uptake in the right knee, localizing to a mass in the popliteal fossa on SPECT/CT. MRI showed a mass encasing the popliteal artery and vein, subsequently found to be non-Hodgkin lymphoma on biopsy. Response of the mass to chemotherapy was documented on ¹⁸F-FDG PET/CT. Elevated In-111 capromab pendetide uptake in soft tissue can be important but unrelated to prostate cancer, as demonstrated in this case. Topics: Aged; Antibodies, Monoclonal; Humans; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2015
Next generation of targeted radiotherapy drugs emerging from the clinical pipeline. Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiation-Sensitizing Agents; Radiopharmaceuticals; Receptors, Peptide; Strontium	2004

Article

Year

Detection of Recurrent Non-Hodgkin Lymphoma on In-111 Capromab Pendetide Imaging.

Clinical nuclear medicine, 2015, Volume: 40, Issue:7

A 73-year-old man presented with a rising prostate-specific antigen (PSA) level 5 years following brachytherapy for prostate cancer. In-111 capromab pendetide (ProstaScint) whole-body planar imaging revealed abnormal uptake in the right knee, localizing to a mass in the popliteal fossa on SPECT/CT. MRI showed a mass encasing the popliteal artery and vein, subsequently found to be non-Hodgkin lymphoma on biopsy. Response of the mass to chemotherapy was documented on ¹⁸F-FDG PET/CT. Elevated In-111 capromab pendetide uptake in soft tissue can be important but unrelated to prostate cancer, as demonstrated in this case.

Topics: Aged; Antibodies, Monoclonal; Humans; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2015

Next generation of targeted radiotherapy drugs emerging from the clinical pipeline.

Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12

Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiation-Sensitizing Agents; Radiopharmaceuticals; Receptors, Peptide; Strontium

2004